Table of Contents

company-logo

Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST), as well as in INTRIGUE Phase 3 study to treat second-line GIST. The company is also developing vimseltinib, an orally administered, potent, and highly selective switch-control kinase inhibitor of colony stimulating factor 1 receptor (CSF1R) for the treatment of tenosynovial giant cell tumor (TGCT); and DCC-3116 to treat RAS/RAF mutant cancers that is in the preclinical-stage. Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.

Deciphera Pharmaceuticals Dividend Announcement

• Deciphera Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Deciphera Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Deciphera Pharmaceuticals Dividend History

Deciphera Pharmaceuticals Dividend Yield

Deciphera Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Deciphera Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Deciphera Pharmaceuticals Financial Ratios

P/E ratio-11.74
PEG ratio-4.45
P/B ratio7.08
ROE-52.42%
Payout ratio0.00%
Current ratio4.19
Quick ratio3.94
Cash Ratio1.09

Deciphera Pharmaceuticals Dividend FAQ

Does Deciphera Pharmaceuticals stock pay dividends?
Deciphera Pharmaceuticals does not currently pay dividends to its shareholders.
Has Deciphera Pharmaceuticals ever paid a dividend?
No, Deciphera Pharmaceuticals has no a history of paying dividends to its shareholders. Deciphera Pharmaceuticals is not known for its dividend payments.
Why doesn't Deciphera Pharmaceuticals pay dividends?
There are several potential reasons why Deciphera Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Deciphera Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Deciphera Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Deciphera Pharmaceuticals a dividend aristocrat?
Deciphera Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Deciphera Pharmaceuticals a dividend king?
Deciphera Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Deciphera Pharmaceuticals a dividend stock?
No, Deciphera Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Deciphera Pharmaceuticals stocks?
To buy Deciphera Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Deciphera Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.